Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

355 POSTS

Exclusive articles:

SKN | Nicolet Bankshares Earnings Preview: Can NIC Sustain Its Strong Growth Momentum?

A Regional Bank Drawing Investor Attention Nicolet Bankshares, Inc. (NYSE: NIC) is heading into its upcoming earnings report on April 15, 2026, with a strong...

SKN | Aduro Clean Technologies Earnings Preview: Can ADUR Turn Innovation Into Profits?

A Clean Tech Story Gaining Market Attention Aduro Clean Technologies Inc. (NASDAQ: ADUR) is heading into its upcoming earnings report on April 14, 2026, as...

SKN | Suja Life Files for $100 Million IPO as Demand for Health-Focused Beverages Grows

Suja Life, a U.S.-based producer of organic and health-oriented soft drinks, has filed for a $100 million initial public offering as it looks to...

SKN | Is SunPower Stock a Hidden Solar Comeback or a Value Trap in Disguise?

A Modest Bounce, But Still Under Pressure SunPower Inc. (SPWR) is currently trading around $1.15, posting a modest daily gain of over 3%. While this...

SKN | The Children’s Place Jumps Ahead of Earnings Despite Deep Structural Weakness

Key Points The Children's Place stock rose short-term ahead of earnings, but remains deeply down long-term, reflecting structural challenges. Persistent losses and repeated earnings...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img